Serum TARC levels are well correlated with clinical scores for atopic dermatitis, and TARC has been used as clinical biomarker for the treatment of atopic dermatitis [48], suggesting the importance of this chemokine in the pathogenesis of atopic dermatitis. The gene discussed is CCL17; the disease is atopic eczema.